← Leaderboards
Larry W Moreland
University Of Alabama At Birmingham
$6,875,808
Attributed
$12,126,048
Total exposure
18
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,126,048 · 18
By mechanism
UC2$4,499,382 · 1
RC2$2,872,161 · 1
K30$1,584,956 · 2
UH2$1,171,870 · 1
N01$804,818 · 1
R21$601,638 · 2
Top collaborators
- Jennifer Anolik8 shared
- Laura T. Donlin8 shared
- Mandy J Mcgeachy5 shared
- Jay K Kolls3 shared
- Marc C. Levesque3 shared
- Kimberly P Liang3 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Timothy J Ness$5,984,098
- S Louis Bridges$17,248,299
- Maria Ioana Danila$2,550,779
- Jeffrey R. Curtis$9,424,518
- Kevin F Dybvig$9,442,249
Others in their field
Top investigators on “Rheumatoid Arthritis”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
- Lionel B Ivashkiv · Hospital For Special Surgery$38,096,851
- Paul M. Ridker · Brigham And Women'S Hospital$34,275,148
- V Michael Holers · University Of Colorado Denver$28,178,502
- Michael B Brenner · Brigham And Women'S Hospital$26,598,289
- Betty Diamond · Feinstein Institute For Medical Research$20,428,564
Research focus
Rheumatoid ArthritisClinical ResearchFundingMethotrexateInflammatoryImmuneBiological Response Modifier TherapyBiologicalSpecimenBiopsySynovitisUnited States National Institutes Of HealthCellsCohortAutoantibodiesPathway InteractionsEnrollmentTissuesPathogenesisSamplingSiteProtocols DocumentationFibroblastsResponse
Grant awards (46)
AIM-for-RA$530,381
UC2 · FY2025 · AR
AIM-for-RA$41,581
UC2 · FY2025 · AR
AIM-for-RA$28,038
UC2 · FY2025 · AR
AIM-for-RA$813,246
UC2 · FY2024 · AR
AIM-for-RA$278,837
UC2 · FY2024 · AR
AIM-for-RA$1,600,000
UC2 · FY2023 · AR
Pain and synovial pathotypes in AMP AIM$307,299
UC2 · FY2023 · AR
AIM-for-RA$900,000
UC2 · FY2022 · AR
Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis?$153,467
R21 · FY2019 · AR
UPITT Rheumatoid Arthritis Combined Center (UPITT RACC)$25,809
UH2 · FY2019 · AR · contact PI
UPITT Rheumatoid Arthritis Combined Center (UPITT RACC)$256,278
UH2 · FY2017 · AR · contact PI
Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis?$153,467
R21 · FY2017 · AR
UPITT Rheumatoid Arthritis Combined Center (UPITT RACC)$251,859
UH2 · FY2016 · AR · contact PI
Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis?$187,079
R21 · FY2016 · AR
UPITT Rheumatoid Arthritis Combined Center (UPITT RACC)$137,922
UH2 · FY2016 · AR · contact PI
UPITT Rheumatoid Arthritis Combined Center (UPITT RACC)$250,001
UH2 · FY2015 · AR · contact PI
UPITT Rheumatoid Arthritis Combined Center (UPITT RACC)$250,001
UH2 · FY2014 · AR · contact PI
Randomized observation study of biologic therapy for rheumatoid arthritis$1,366,857
RC2 · FY2010 · AR · contact PI
Randomized observation study of biologic therapy for rheumatoid arthritis$164,718
RC2 · FY2010 · AR · contact PI
Randomized observation study of biologic therapy for rheumatoid arthritis$1,340,586
RC2 · FY2009 · AR · contact PI
Rheumatoid Arthritis Induction Trial (RAITMAT)$148,500
R34 · FY2007 · AR · contact PI
ANTIBODIES AND MARKERS OF DISEASE ACTIVITY IN PATIENTS WITH AUTOIMMUNE DISEASES$1,384
M01 · FY2007 · RR · contact PI
UAB Clinical Research Training Program$300,000
K30 · FY2006 · RR · contact PI
ANTIBODIES AND MARKERS OF DISEASE ACTIVITY IN PATIENTS WITH AUTOIMMUNE DISEASES$19,270
M01 · FY2006 · RR · contact PI
CONSORTIUM FOR THE LONGITUDINAL EVALUATION OF AFRICAN AMERICANS WITH EA (CLEAR)$15,745
M01 · FY2006 · RR · contact PI
TEAR$6,815
M01 · FY2006 · RR · contact PI
AUTOIMMUNE BIOMARKERS COLLABORATIVE NETWORK$470
M01 · FY2006 · RR · contact PI
UAB Clinical Research Training Program$300,000
K30 · FY2005 · RR
CONSORTIUM FOR THE LONGITUDINAL EVALUATION OF AFRICAN AMERICANS WITH EA (CLEAR)$6,995
M01 · FY2005 · RR
ANTIBODIES AND MARKERS OF DISEASE ACTIVITY IN PATIENTS WITH AUTOIMMUNE DISEASES$4,746
M01 · FY2005 · RR
AUTOIMMUNE BIOMARKERS COLLABORATIVE NETWORK$1,749
M01 · FY2005 · RR
TEAR$1,499
M01 · FY2005 · RR
BOVINE COLLAGEN IN SCLERODERMA$500
M01 · FY2005 · RR
CLINICAL RESEARCH TRAINING PROGRAM$196,618
K30 · FY2004 · HL
Bovine collagen in scleroderma$7,195
M01 · FY2004 · RR
African Americans with Early Rheumatoid Arthritis$2,491
M01 · FY2004 · RR
Autoimmune Biomarkers Collaborative Network$830
M01 · FY2004 · RR
CLINICAL RESEARCH TRAINING PROGRAM$196,618
K30 · FY2003 · HL
CLINICAL RESEARCH TRAINING PROGRAM$196,618
K30 · FY2002 · HL
CLINICAL RESEARCH TRAINING PROGRAM$199,424
K30 · FY2001 · HL
Clinical Research Training For Studies of CVD in India$113,400
D43 · FY2001 · TW
Treatment of Early Aggressive Rheumatoid Arthritis TEAR$107,625
R21 · FY2001 · AR
CLEAR$804,818
N01 · FY2000 · AR
MECHANISMS OF TISSUE INJURY IN RHEUMATOID ARTHRITIS$259,634
R01 · FY2000 · AR
CLINICAL RESEARCH TRAINING PROGRAM$195,678
K30 · FY2000 · HL
SYNOVIAL BIOPSY PROCEDURE FOR ENBREL$0
M01 · FY2000 · RR